Moderna, Inc.'s stock plummets as challenges mount, including vaccine skepticism, competitive pressures, and the RFK ...

Moderna stock is undervalued with a $97 price target, strong COVID-19 revenue, promising pipeline, and long-term growth. Read ...

Moderna’s top executives have sought to reassure investors they will be able to carry out the comeback plans announced in ...

Marty Makary, an outspoken critic of the nation’s food and drug regulator, stands to shake up the FDA’s standards in science ...

KEY TAKEAWAYS Moderna shares surged further Friday, a day after a senior executive made bullish comments at a healthcare ...

As the biopharma industry braces for a second term under President-elect Donald Trump, speculation is swirling around the ...

We recently compiled a list of the 10 Most Promising Cancer Stocks According to Hedge Funds. In this article, we are going to ...

Moderna has secured FDA approval for its respiratory syncytial virus (RSV) vaccine, giving it a chance to generate revenue from a second product as sales of its Spikevax COVID-19 shot have slumped.

We recently compiled a list of the 10 Oversold Healthcare Stocks To Invest In. In this article, we are going to take a look ...

Take an at-home COVID test when you feel sick, or go to an urgent care where you can be tested for COVID, RSV, and influenza ...

MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside ... Keytruda has been approved by the FDA as a surgery-spanning immunotherapy in ...